HealthChampion Reinforces Company’s Commitment to ‘Thinking Healthier’ with New Name, Calcium

HealthChampion, a digital health analytics and data management company, has changed its name and is now called Calcium. The company will continue to empower healthier lives with intuitive digital tools. The company rebrand was effective Dec. 11, 2021.

“We’re thrilled to begin this new journey with our customers as Calcium,” says Sid Bala, President of Calcium. “Since we began in 2018, our mission has been to put more power in the hands of people. That has led us to continually think about how our company helps individuals lead healthier lives. We’re excited to continue to give people and their health teams unparalleled access to meaningful insights and personalized guidance.”

Calcium believes a healthier world starts with informed decisions, and that starts with better data. That’s why Calcium provides easy and fun-to-use tools to facilitate healthier decisions. Calcium empowers individuals to stay engaged with their health through personalized pathways. Ultimately, a more informed individual can easily collaborate with their health team or family members to monitor and improve their wellbeing for a truly unified experience.

“The word ‘calcium’, as an essential nutrient, connotes strength and health,” explains Jen Adamski, managing director of marketing. “At Calcium, we provide a secure platform that puts individuals in control of their health journey. Our new name honors our long-standing commitment to providing essential tools and insights. Everything people have come to trust about our company remains the same.”

Calcium’s online dashboard and mobile app integrates health data from apps, devices and health records to produce insights that facilitate better decision-making. Calcium’s tools also benefit businesses and health professionals. By giving providers, payors and businesses an easy-to-use platform powered by data analytics with real-time insights and trend analyses, Calcium builds healthier workplaces, more efficient practices, and more satisfied patients.

The transition to Calcium is seamless for individuals and clients. The product interface, whether app or online dashboard, remains consistent and accessible. App functionality will stay the same and can be found under the new name in the Apple Store and on Google Play. Regular app updates will be available as usual.

Calcium takes privacy and regulatory compliance seriously. The company has held HIPAA compliance at the forefront of their efforts since the beginning. Calcium’s enterprise architect conducts regular audits to ensure all of the company’s offerings are secure and conform to the relevant rules, laws and standards governing digital health products and services.

SourceCalcium

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”